Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

Pier Luigi Meroni, Paolo Macor, Paolo Durigutto, Luca De Maso, Maria Gerosa, Mariano Ferraresso, Maria Orietta Borghi, Tom Eirik Mollnes, Francesco Tedesco

Blood (2016) 127 (3): 365–367.

https://doi.org/10.1182/blood-2015-09-672139

Published: 2016

Journal Articles

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

Chiara Agostinis, Paolo Durigutto, Daniele Sblattero, Maria O. Borghi, Claudia Grossi, Filomena Guida, Roberta Bulla, Paolo Macor, Francesca Pregnolato, Pier Luigi Meroni, Francesco Tedesco

Blood (2014) 123 (22): 3478–3487.

https://doi.org/10.1182/blood-2013-11-537704

Published: 2014

Includes: Supplemental data

Journal Articles

Toll like Receptor 4 Is Involved in In VIvo Antiphospholipid-Mediated Thrombosis and Endothelial Cell Activation.

Silvia S. Pierangeli, PhD, Mariano E. Vega-Ostertag, MS, Elena Raschi, PhD, Xiaowei Liu, MD, Maria O. Borghi, PhD, Pier Luigi Meroni, MD

Blood (2005) 106 (11): 133.

https://doi.org/10.1182/blood.V106.11.133.133

Published: 2005

Journal Articles

Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients

Massimo Cugno, Mara Cabibbe, Monica Galli, Pier Luigi Meroni, Sonia Caccia, Rosaria Russo, Bianca Bottasso, Pier Mannuccio Mannucci

Blood (2004) 103 (6): 2121–2126.

https://doi.org/10.1182/blood-2003-07-2422

Published: 2004

Journal Articles

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

Elena Raschi, Cinzia Testoni, Daniela Bosisio, Maria O. Borghi, Takao Koike, Alberto Mantovani, Pier Luigi Meroni

Blood (2003) 101 (9): 3495–3500.

https://doi.org/10.1182/blood-2002-08-2349

Published: 2003

NARROW

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

Toll like Receptor 4 Is Involved in In VIvo Antiphospholipid-Mediated Thrombosis and Endothelial Cell Activation.

Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

Email alerts

ASH Publications

American Society of Hematology

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

Toll like Receptor 4 Is Involved in In VIvo Antiphospholipid-Mediated Thrombosis and Endothelial Cell Activation.

Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only